drugset / Trial / NCT02130453
Accuracy of an Echo-Stress Protocol Using Regadenoson With Speckle Tracking
Phase 4
Completed
161 enrolled
M.D. Anderson Cancer Center
Astellas Scientific & Medical Affairs, Inc. · collab
Non-randomizedSingle-groupSingle-blindDiagnostic
Summary
The goal of this clinical research study is to compare regadenoson nuclear stress testing with echocardiography strain measurements (an ultrasound imaging method that measures hearts function) in detecting coronary artery disease.
Timeline
- Start
- 2014-09-30
- Primary completion
- 2024-06-28
- Completion
- 2024-06-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Regadenoson | Diagnostic / imaging agent | 0.4 mg | Intravenous |